The Swedish imaging IT and cybersecurity company best known as a highly rated PACS supplier has retooled its enterprise imaging platform to incorporate genomics data.
Linköping-based Sectra announced the development Aug. 31, noting the growing importance of genetic information to personalizing cancer care and other branches of healthcare in which precision medicine may be applied.
The company says the genomics IT arm immediately becomes a new business unit under its business innovation umbrella.
The unit is to be led by bioinformaticist Fredrik Lysholm, PhD, who previously worked for Sectra as a software engineer and, most recently, as head of pilot projects and “focused development efforts,” according to Lysholm’s profile at LinkedIn.
Sectra says it’s working with the University of Pennsylvania Health System, aka Penn Medicine, to develop an IT solution related to the business expansion.
More from the announcement:
The IT solution for genomic information will be part of Sectra’s enterprise imaging solution, which provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise.”
The company’s president and CEO, Torbjörn Kronander, remarks that investing in genomics “fits perfectly with our long-term ambition to be the leader in diagnostics information technology and has the potential to significantly impact patient care.”
Sectra PACS has been a perennial presence at the top of the annual “Best in KLAS” awards for the past decade or so, most recently winning four in 2022.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.